United States Cell and Gene Therapy Third-Party Logistics Market Size and Forecast (2025–2033) According To Renub Research United States cell and gene therapy third-party logistics (3PL) market is poised for robust growth over the forecast period from 2025 to 2033. The market, valued at approximately USD 2.61 billion in 2024, is projected to reach nearly USD 5.88 billion by 2033,...